Integrative Management of Anorectal Malignancies to Optimize Patient Outcomes with Sharon Gurm, ND, FABNO
1.5 CE (.25 rx)
Learning Objectives:
Identify the key drivers of malignant anorectal and anal pathology
Understand the presenting features, diagnosis and standard of care treatment for anorectal and anal malignancies
Know the current evidence supporting complementary therapies in the setting of primary treatment and recurrence prevention of anorectal and anal malignancies
Learn innovative strategies to improve compete response in the neoadjuvant setting to avoid surgery or improve surgical outcomes and achieve durable remission (recurrence prevention).
Identify the ideal candidates for the PDT-HT approach
1.5 CE (.25 rx)
Learning Objectives:
Identify the key drivers of malignant anorectal and anal pathology
Understand the presenting features, diagnosis and standard of care treatment for anorectal and anal malignancies
Know the current evidence supporting complementary therapies in the setting of primary treatment and recurrence prevention of anorectal and anal malignancies
Learn innovative strategies to improve compete response in the neoadjuvant setting to avoid surgery or improve surgical outcomes and achieve durable remission (recurrence prevention).
Identify the ideal candidates for the PDT-HT approach
1.5 CE (.25 rx)
Learning Objectives:
Identify the key drivers of malignant anorectal and anal pathology
Understand the presenting features, diagnosis and standard of care treatment for anorectal and anal malignancies
Know the current evidence supporting complementary therapies in the setting of primary treatment and recurrence prevention of anorectal and anal malignancies
Learn innovative strategies to improve compete response in the neoadjuvant setting to avoid surgery or improve surgical outcomes and achieve durable remission (recurrence prevention).
Identify the ideal candidates for the PDT-HT approach